In this issue:
- Aspirin vs. LMWH for postfracture thromboprophylaxis
- Intravenous thrombolysis in ischaemic stroke, and recent DOAC use
- FXI inhibitors versus LMWH for preventing VTE in major orthopaedic surgery
- Cyclophosphamide-dexamethasone-rituximab for acquired haemophilia A
- Long-term emicizumab prophylaxis in haemophilia A with FVIII inhibitors
- Autoantibody targets in acquired haemophilia A not restricted to FVIII
- ITP and pregnancy
- D-dimer and reduced-dose apixaban for extended treatment after unprovoked VTE
- Gynaecological and obstetric management of women with VWD
- Long-term relapse risk in immune-mediated TTP: role of anti-CD20 therapy
- Efanesoctocog alfa prophylaxis in severe haemophilia A
Please login below to download this issue (PDF)